We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-2.44%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$81.5B
AUM Growth
-$7.54B
Cap. Flow
-$4.7B
Cap. Flow %
-5.76%
Top 10 Hldgs %
11.71%
Holding
2,587
New
39
Increased
604
Reduced
1,359
Closed
377

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$147M
2
PYPL icon
PayPal
PYPL
+$116M
3
NFLX icon
Netflix
NFLX
+$113M
4
KLAC icon
KLA
KLAC
+$99.9M
5
ZBRA icon
Zebra Technologies
ZBRA
+$92.9M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$252M
2
GFS icon
GlobalFoundries
GFS
+$151M
3
UBER icon
Uber
UBER
+$140M
4
LLY icon
Eli Lilly
LLY
+$137M
5
META icon
Meta Platforms (Facebook)
META
+$132M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 15.61%
3 Financials 13.64%
4 Industrials 9.96%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWBI icon
2101
Northwest Bancshares
NWBI
$2.25B
-16,536
Closed -$230K
TRS icon
2102
TriMas Corp
TRS
$1.43B
-984
Closed -$27.1K
TTEC icon
2103
TTEC Holdings
TTEC
$103M
$25K ﹤0.01%
212
-362
-63% -$21.5K
TXG icon
2104
10x Genomics
TXG
$5.87B
-76,524
Closed -$2.92M
IMGN
2105
DELISTED
Immunogen Inc
IMGN
$25K ﹤0.01%
1,834
-3,361
-65% -$17.7K
BEAM icon
2106
Beam Therapeutics
BEAM
$2.58B
-510
Closed -$29.1K
CIVI
2107
DELISTED
Civitas Resources
CIVI
-414
Closed -$24.4K
EDIT icon
2108
Editas Medicine
EDIT
$399M
$24K ﹤0.01%
1,190
-767
-39% -$12K
HLX icon
2109
Helix Energy Solutions
HLX
$1.46B
$24K ﹤0.01%
6,312
-2,969,154
-100% -$11.3M
OII icon
2110
Oceaneering
OII
$5.25B
$24K ﹤0.01%
2,960
PRAA icon
2111
PRA Group
PRAA
$648M
-733
Closed -$27.3K
RKT icon
2112
Rocket Companies
RKT
$36.9B
$24K ﹤0.01%
1,579
-2,239
-59% -$19.5K
XENE icon
2113
Xenon Pharmaceuticals
XENE
$6.32B
$24K ﹤0.01%
132
-539
-80% -$19.4K
MODN
2114
DELISTED
MODEL N, INC.
MODN
-712
Closed -$20.6K
GMVD
2115
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
$24K ﹤0.01%
+2,924
New +$43K
ACVA icon
2116
ACV Auctions
ACVA
$1.35B
-3,146
Closed -$25K
BBBY
2117
Bed Bath & Beyond
BBBY
$473M
$23K ﹤0.01%
550
-505
-48% -$12.7K
OTTR icon
2118
Otter Tail
OTTR
$3.88B
-380
Closed -$27.4K
PBI icon
2119
Pitney Bowes
PBI
$2.42B
$23K ﹤0.01%
8,045
-1,752
-18% -$5.62K
TLRY icon
2120
Tilray
TLRY
$479M
-854
Closed -$30K
VSAT icon
2121
Viasat
VSAT
$9.79B
$23K ﹤0.01%
490
-285
-37% -$9.54K
CTLP
2122
DELISTED
Cantaloupe
CTLP
$22K ﹤0.01%
6,318
EBS icon
2123
Emergent Biosolutions
EBS
$375M
$22K ﹤0.01%
465
-562
-55% -$15.6K
FSLY icon
2124
Fastly Inc
FSLY
$3.17B
$22K ﹤0.01%
1,026
-1,348
-57% -$14.4K
GBX icon
2125
The Greenbrier Companies
GBX
$1.61B
-898
Closed -$27.1K

Similar funds

Macquarie Group's Q3 2022 Portfolio in Review

As of Q3 2022, Macquarie Group held 2,587 positions worth $81.5B, down 8.5% from $89.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Macquarie Group withdrew a net $4.7B in Q3 2022, closing 377 positions and reducing 1,359 holdings. Its most notable exit was Macquarie Infrastructure Holdings, LLC, an estimated $59.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in EngageSmart, Inc. worth $25.9M.

  • Macquarie Group's largest Q3 2022 buy was EngageSmart, Inc.: 1,250,903 shares worth $25.9M.
  • Macquarie Group added most to Aptiv in Q3 2022, an estimated $147M increase.
  • Macquarie Group's biggest Q3 2022 reduction was Mastercard, cutting an estimated $252M.
  • Macquarie Group fully exited Macquarie Infrastructure Holdings, LLC in Q3 2022, selling an estimated $59.3M.
  • Macquarie Group's ten largest holdings make up 12% of its $81.5B portfolio in Q3 2022.
  • Macquarie Group opened 39 new positions and closed 377 in Q3 2022.
  • Macquarie Group's portfolio value fell 8.5% quarter-over-quarter to $81.5B.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.